Next Article in Journal
Diagnostic Accuracy of the InBios Scrub Typhus Detect™ ELISA for the Detection of IgM Antibodies in Chittagong, Bangladesh
Next Article in Special Issue
Mycetoma: The Spectrum of Clinical Presentation
Previous Article in Journal
‘Know Your Epidemic’: Are Prisons a Potential Barrier to TB Elimination in an Australian Context?
Previous Article in Special Issue
Advances in the Treatment of Yaws
Open AccessReview

Onchodermatitis: Where Are We Now?

Department of Dermatology, West Herts Hospitals NHS Trust, Vicarage Road, Watford, Hertfordshire WD18 0HB, UK
Trop. Med. Infect. Dis. 2018, 3(3), 94;
Received: 30 July 2018 / Revised: 27 August 2018 / Accepted: 28 August 2018 / Published: 1 September 2018
Onchocerciasis causes debilitating pruritus and rashes as well as visual impairment and blindness. Prior to control measures, eye disease was particularly prominent in savanna areas of sub-Saharan Africa whilst skin disease was more common across rainforest regions of tropical Africa. Mass drug distribution with ivermectin is changing the global scene of onchocerciasis. There has been successful progressive elimination in Central and Southern American countries and the World Health Organization has set a target for elimination in Africa of 2025. This literature review was conducted to examine progress regarding onchocercal skin disease. PubMed searches were performed using keywords ‘onchocerciasis’, ‘onchodermatitis’ and ‘onchocercal skin disease’ over the past eight years. Articles in English, or with an English abstract, were assessed for relevance, including any pertinent references within the articles. Recent progress in awareness of, understanding and treatment of onchocercal skin disease is reviewed with particular emphasis on publications within the past five years. The global burden of onchodermatitis is progressively reducing and is no longer seen in children in many formerly endemic foci. View Full-Text
Keywords: onchodermatitis; onchocercal skin disease; onchocerciasis; ivermectin onchodermatitis; onchocercal skin disease; onchocerciasis; ivermectin
MDPI and ACS Style

Murdoch, M.E. Onchodermatitis: Where Are We Now? Trop. Med. Infect. Dis. 2018, 3, 94.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop